Ovid Therapeutics
OVID
OVID
48 hedge funds and large institutions have $54.5M invested in Ovid Therapeutics in 2018 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 20 increasing their positions, 11 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
more funds holding
Funds holding: →
0% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 9
Holders
48
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$2.08M | |
| 2 | +$939K | |
| 3 | +$345K | |
| 4 |
State Street
Boston,
Massachusetts
|
+$273K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$212K |
Top Sellers
| 1 | -$2M | |
| 2 | -$903K | |
| 3 | -$556K | |
| 4 |
Millennium Management
New York
|
-$346K |
| 5 |
RG
Redmile Group
San Francisco,
California
|
-$302K |